L. Sangare et al., Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice, J ANTIMICRO, 47(3), 2001, pp. 323-331
In a previous study, we demonstrated that cationic liposome-encapsulated do
xycycline (CaL-Dox) was two-fold more effective than free doxycycline again
st Chlamydia trachomatis in vitro. Here, we evaluated the effects of two Ca
L-Dox regimens in comparison with unencapsulated doxycycline on the course
of chlamydial genital infection in mice. Progesterone-treated, female CF-1
mice were challenged intravaginally with 1.2 x 10(5) inclusion-forming unit
s (ifu) of C. trachomatis. Two days post-infection, the animals were divide
d into four treatment groups for im injection of doxycycline at 10 mg/kg bo
dy weight bd for 3 (3 Dox) or 7 days (7 Dox), or of CaL-Dox at the same dos
e level for 3 (3 CaL-Dox) or 7 days (7 CaL-Dox) consecutively. An infected
fifth group served as a control and was given an empty Cat preparation. C.
trachomatis were isolated after five blind passages from 82% of infected co
ntrol mice, 61.4% of 3 Dox, 52.2% of 3 CaL-Dox, 29% of 7 Dox and 20% of 7 C
aL-Dox animals. Histopathological reactions were found in various tissues o
f the genital tract in 79.5% of infected control mice, 80.9% of 3 Dox, 65.2
% of 3 CaL-Dox, 47.1% of 7 Dox and 25.7% of 7 CaL-Dox animals. Total antich
lamydial antibody titres were lower in 7 CaL-Dox mice than in all the other
groups(P < 0.005). The results showed that progesterone-treated CF-1 mice
are suitable for investigation of both lower and upper genital tract infect
ion with a lymphogranuloma venereum biovar strain of C. trachomatis. Neithe
r 7 CaL-Dox nor 3 CaL-Dox treatment was more effective than unencapsulated
7 Dox doses in the bacteriological cure of chlamydial genital infection in
mice. However; 7 CaL-Dox prevented tissue damage in the genital tract signi
ficantly more than all the other regimens (P < 0.05). These results suggest
that liposome-encapsulated doxycycline, particularly CaL-Dox, may have pot
ential for the clinical treatment of chlamydial infections.